Find a Doctor or Practice Location

You can also search for providers and practices at Penn Medicine Lancaster General Health or Princeton Health.

I am searching for a
Reset Form
Chenbo Zeng, PhD

Chenbo Zeng, PhD Researcher

Research Assistant Professor of Radiology

Dr. Zeng is employed by Penn Medicine.

No Patient Satisfaction Reviews
Why not?

There is no publicly available rating for this medical professional for one of the following reasons:

  1. He or she is not employed by Penn Medicine.
  2. He or she does not see patients in a medical practice setting.
  3. He or she sees patients but has not yet received the minimum 30 patient satisfaction reviews in the past 12 months, ensuring that the rating is statistically reliable and a true reflection of patient satisfaction.


American Association for Cancer Research, National Society for Neuroscience, National

Hospital Affiliation

Dr. Zeng is employed by Penn Medicine.


Description of Research Expertise:

Studying the biological functions of the sigma-2 receptor in breast cancer and in the central nervous system

Selected Publications:

Chenbo Zeng, Elizabeth S. McDonald, Robert H Mach: Molecular probes for imaging the sigma-2 receptor: in vitro and in vivo imaging studies Handb Exp Pharmacol. Sigma Proteins - Molecular pharmacology in physiology and pathophysiology : 2017.

Sellmyer MA, Lee I, Hou C, Lieberman BP, Zeng C, Mankoff DA, Mach RH.: Quantitative PET Reporter Gene Imaging with [11C]Trimethoprim. Mol Ther. 25 (1): 120-126,2017.

Elizabeth S. McDonald, Julia Mankoff, Mehran Makvandi, Wenhua Chu, Yunxiang Chu, Robert H Mach, Chenbo Zeng: Sigma-2 ligands and PARP inhibitors synergistically trigger cell death in breast cancer cells Biochemical and Biophysical Research Communications 486 : 788-795 ,2017.

Chenbo Zeng and Robert H. Mach: The Evolution of the Sigma-2 Receptor from Obscure Binding Site to Bona Fide Therapeutic Target Adv Exp Med Biol. Sigma Receptors: Their Role in Disease and as Therapeutic Targets 964 : 49-61,2017.

Makvandi M, Xu K, Lieberman BP, Anderson RC, Effron SS, Winters HD, Zeng C, McDonald ES, Pryma DA, Greenberg RA, Mach RH.: A Radiotracer Strategy to Quantify PARP-1 Expression In Vivo Provides a Biomarker That Can Enable Patient Selection for PARP Inhibitor Therapy. Cancer Res. 76(15) : 4516-24,2016.

Edmonds CE, Makvandi M, Lieberman BP, Xu K, Zeng C, Li S, Hou C, Lee H, Greenberg RA, Mankoff DA, Mach RH.: [(18)F]FluorThanatrace uptake as a marker of PARP1 expression and activity in breast cancer. Am J Nucl Med Mol Imaging. 6 : 94-101,2016.

Zeng C, Garg N, Mach RH.: The PGRMC1 Protein Level Correlates with the Binding Activity of a Sigma-2 Fluorescent Probe (SW120) in Rat Brain Cells. Mol Imaging Biol. 18 : 172-9,2016.

Anderson RC, Makvandi M, Xu K, Lieberman BP, Zeng C, Pryma DA, Mach RH.: Iodinated benzimidazole PARP radiotracer for evaluating PARP1/2 expression in vitro and in vivo Nucl Med Biol. 43 (12): 752-758,2016.

Makvandi M, Tilahun ED, Lieberman BP, Anderson RC, Zeng C, Xu K, Hou C, McDonald ES, Pryma DA, Mach RH.: The sigma-2 receptor as a therapeutic target for drug delivery in triple negative breast cancer. Biochem Biophys Res Commun 467 : 1070-5,2015 .

Elizabeth S. McDonald, Chenbo Zeng, David A Mankoff, Andrew Kossenkov, Robert H Mach: PGRMC1 expression is significantly up-regulated in triple negative breast cancer in vivo with associated activation of cyclin D1 target genes: Analysis of 1019 invasive breast cancers in the TCGA database 2015 Annual Meeting American Association for Cancer Research : 2015.

Academic Contact Info

Department of Radiology
University of Pennsylvania
3400 Spruce Street

Philadelphia, PA 19104
Phone: (215) 746-2511